Cargando…
A Bowman–Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition
Proteasome inhibitors are emerging as a new class of chemopreventive agents and have gained huge importance as potential pharmacological tools in breast cancer treatment. Improved understanding of the role played by proteases and their specific inhibitors in humans offers novel and challenging oppor...
Autores principales: | Mehdad, A, Brumana, G, Souza, AA, Barbosa, JARG, Ventura, MM, de Freitas, SM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979482/ https://www.ncbi.nlm.nih.gov/pubmed/27551492 http://dx.doi.org/10.1038/cddiscovery.2015.67 |
Ejemplares similares
-
Effects of an Anticarcinogenic Bowman-Birk Protease Inhibitor on Purified 20S Proteasome and MCF-7 Breast Cancer Cells
por: Souza, Larissa da Costa, et al.
Publicado: (2014) -
Blood pressure-lowering effects of a Bowman-Birk inhibitor and its derived peptides in normotensive and hypertensive rats
por: de Freitas, Maria Alzira Garcia, et al.
Publicado: (2020) -
Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages
por: Li, Jieliang, et al.
Publicado: (2011) -
Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019)